Evidence map›Paper›PMID 34503118›Full record

ReviewCancers2021

Bone Metastatic Breast Cancer: Advances in Cell Signaling and Autophagy Related Mechanisms.

Ahmad Othman, Marcus Winogradzki, Linus Lee, Manish Tandon, Alan Blank, Jitesh Pratap

Open access · goldAbstract readReview
In one paragraph

Review in Cancers, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.7field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Plant Extracts fromInternational journal of molecular sciences · 2026
    Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Dual role of autophagy in bone metastasis: mechanistic insights and therapeutic targeting.American journal of clinical and experimental urology · 2025
    Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. MiR-30 Family: A Novel Avenue for Treating Bone and Joint Diseases?International journal of medical sciences · 2023
    Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Ahmad OthmanDepartment of Anatomy & Cell Biology, Cell & Molecular Medicine, Rush University Medical Center, Chicago, IL 60612, USA.ORCID 0000-0001-9995-1233
Marcus WinogradzkiDepartment of Anatomy & Cell Biology, Cell & Molecular Medicine, Rush University Medical Center, Chicago, IL 60612, USA.
Linus LeeDepartment of Anatomy & Cell Biology, Cell & Molecular Medicine, Rush University Medical Center, Chicago, IL 60612, USA.
Manish TandonDepartment of Anatomy & Cell Biology, Cell & Molecular Medicine, Rush University Medical Center, Chicago, IL 60612, USA.
Alan BlankDepartment of Anatomy & Cell Biology, Cell & Molecular Medicine, Rush University Medical Center, Chicago, IL 60612, USA.
Jitesh PratapDepartment of Anatomy & Cell Biology, Cell & Molecular Medicine, Rush University Medical Center, Chicago, IL 60612, USA.
Rush University Medical Center · US

Funding

Regulation of autophagy in bone metastasisR21CA245609 · NCI · RUSH UNIVERSITY MEDICAL CENTER · PI PRATAP, JITESH · 2020 to 2022
$358k
NCI NIH HHS R21 CA245609NCI NIH HHS R21CA245609
6 · The paper itself

Abstract

Bone metastasis is a frequent complication of breast cancer with nearly 70% of metastatic breast cancer patients developing bone metastasis during the course of their disease. The bone represents a dynamic microenvironment which provides a fertile soil for disseminated tumor cells, however, the mechanisms which regulate the interactions between a metastatic tumor and the bone microenvironment remain poorly understood. Recent studies indicate that during the metastatic process a bidirectional relationship between metastatic tumor cells and the bone microenvironment begins to develop. Metastatic cells display aberrant expression of genes typically reserved for skeletal development and alter the activity of resident cells within the bone microenvironment to promote tumor development, resulting in the severe bone loss. While transcriptional regulation of the metastatic process has been well established, recent findings from our and other research groups highlight the role of the autophagy and secretory pathways in interactions between resident and tumor cells during bone metastatic tumor growth. These reports show high levels of autophagy-related markers, regulatory factors of the autophagy pathway, and autophagy-mediated secretion of matrix metalloproteinases (MMP's), receptor activator of nuclear factor kappa B ligand (RANKL), parathyroid hormone related protein (PTHrP), as well as WNT5A in bone metastatic breast cancer cells. In this review, we discuss the recently elucidated mechanisms and their crosstalk with signaling pathways, and potential therapeutic targets for bone metastatic disease.

Indexed as

autophagybone metastasisbreast cancercell signalingmicroenvironment-derived factorstumor-derived factors

Identifiers

PMID34503118
PMCPMC8431094
OpenAlexW3196071286

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.